UIM
MRNA icon

USS Investment Management’s Moderna MRNA Stock Holding History

USS Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-73,697
Closed -$2.09M – 541
2025
Q1 		$2.09M Hold
73,697
– – 0.02% 487
2024
Q4 		$3.06M Sell
73,697
-3,798
-5% -$182K 0.02% 472
2024
Q3 		$5.18M Sell
77,495
-2,762
-3% -$254K 0.04% 396
2024
Q2 		$9.53M Buy
80,257
+2,241
+3% +$284K 0.08% 210
2024
Q1 		$8.32M Buy
78,016
+8,634
+12% +$870K 0.07% 239
2023
Q4 		$6.9M Sell
69,382
-3,000
-4% -$252K 0.06% 268
2023
Q3 		$7.48M Buy
72,382
+10,508
+17% +$1.17M 0.08% 250
2023
Q2 		$7.52M Hold
61,874
– – 0.09% 252
2023
Q1 		$9.5M Sell
61,874
-626
-1% -$103K 0.13% 170
2022
Q4 		$11.2M Sell
62,500
-2,666
-4% -$436K 0.16% 140
2022
Q3 		$7.71M Sell
65,166
-17,939
-22% -$2.72M 0.11% 189
2022
Q2 		$11.9M Sell
83,105
-6,855
-8% -$980K 0.12% 179
2022
Q1 		$15.5M Buy
89,960
+13,046
+17% +$2.2M 0.13% 166
2021
Q4 		$19.5M Hold
76,914
– – 0.15% 136
2021
Q3 		$29.6M Buy
76,914
+9,956
+15% +$3.67M 0.25% 92
2021
Q2 		$15.7M Hold
66,958
– – 0.12% 134
2021
Q1 		$8.77M Buy
66,958
+59,958
+857% +$8.69M 0.08% 165
2020
Q4 		$731K Hold
7,000
– – 0.01% 528
2020
Q3 		$495K Hold
7,000
– – ﹤0.01% 549
2020
Q2 		$450K Buy
+7,000
New +$383K ﹤0.01% 553

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

USS Investment Management's MRNA Position: Q2 2025 in Review

USS Investment Management sold out of Moderna (MRNA) in Q2 2025, closing a stake of 73,697 shares — an estimated $2.09M sold.

USS Investment Management first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $29.6M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • USS Investment Management reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • USS Investment Management sold 73,697 Moderna shares in Q2 2025, an estimated $2.09M.
  • USS Investment Management first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • USS Investment Management's Moderna position peaked at $29.6M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on USS Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.